Dr Eugenio Rivera Jr, MD - Medicare Diagnostic Radiology in Albuquerque, NM

Dr Eugenio Rivera Jr, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Albuquerque, New Mexico. He went to Howard University College Of Medicine and graduated in 1988 and has 36 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Radiology Associates Of Albuquerque Pa and his current practice location is 4411 The 25 Way Ne, Ste 150, Albuquerque, New Mexico. You can reach out to his office (for appointments etc.) via phone at (505) 332-6900.

Dr Eugenio Rivera Jr is licensed to practice in New Mexico (license number 92-167) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1689678393.

Contact Information

Dr Eugenio Rivera Jr, MD
4411 The 25 Way Ne, Ste 150,
Albuquerque, NM 87109-5888
(505) 332-6900
(505) 332-6921



Physician's Profile

Full NameDr Eugenio Rivera Jr
GenderMale
SpecialityDiagnostic Radiology
Experience36 Years
Location4411 The 25 Way Ne, Albuquerque, New Mexico
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Eugenio Rivera Jr attended and graduated from Howard University College Of Medicine in 1988
  NPI Data:
  • NPI Number: 1689678393
  • Provider Enumeration Date: 06/09/2005
  • Last Update Date: 10/18/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 8628037330
  • Enrollment ID: I20041011000246

Medical Identifiers

Medical identifiers for Dr Eugenio Rivera Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1689678393NPI-NPPES
45138MedicaidNM
00014212MedicaidNM
2258272OtherNMMEDICARE GROUP
L0634MedicaidNM
52713MedicaidNM

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 92-167 (New Mexico)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Presbyterian HospitalAlbuquerque, NMHospital
Presbyterian Santa Fe Medical CenterSanta fe, NMHospital
Plains Regional Medical CenterClovis, NMHospital
Lincoln County Medical CenterRuidoso, NMHospital
Presbyterian Espanola HospitalEspanola, NMHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Radiology Associates Of Albuquerque Pa286030448277

News Archive

Study shows impact of optimizing airport flight patterns on human health

Health costs associated with noise from changing flight patterns over populated urban landscapes far outweigh the benefits of reduced flight times, according to a new study conducted at Columbia University's Mailman School of Public Health and Queens Quiet Skies.

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

Warner Chilcott to offer 20,000,000 shares in secondary offering

Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Eugenio Rivera Jr allows following entities to bill medicare on his behalf.
Entity NameRadiology Associates Of Albuquerque Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881666998
PECOS PAC ID: 2860304482
Enrollment ID: O20031103000381

News Archive

Study shows impact of optimizing airport flight patterns on human health

Health costs associated with noise from changing flight patterns over populated urban landscapes far outweigh the benefits of reduced flight times, according to a new study conducted at Columbia University's Mailman School of Public Health and Queens Quiet Skies.

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

Warner Chilcott to offer 20,000,000 shares in secondary offering

Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.

Read more Medical News

› Verified 2 days ago

Entity NameAdvanced Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1558416974
PECOS PAC ID: 2860451648
Enrollment ID: O20070723000756

News Archive

Study shows impact of optimizing airport flight patterns on human health

Health costs associated with noise from changing flight patterns over populated urban landscapes far outweigh the benefits of reduced flight times, according to a new study conducted at Columbia University's Mailman School of Public Health and Queens Quiet Skies.

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

Warner Chilcott to offer 20,000,000 shares in secondary offering

Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Eugenio Rivera Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Eugenio Rivera Jr, MD
4411 The 25 Way Ne, Ste 150,
Albuquerque, NM 87109-5888

Ph: (505) 332-6900
Dr Eugenio Rivera Jr, MD
4411 The 25 Way Ne, Ste 150,
Albuquerque, NM 87109-5888

Ph: (505) 332-6900

News Archive

Study shows impact of optimizing airport flight patterns on human health

Health costs associated with noise from changing flight patterns over populated urban landscapes far outweigh the benefits of reduced flight times, according to a new study conducted at Columbia University's Mailman School of Public Health and Queens Quiet Skies.

Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform

Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

Warner Chilcott to offer 20,000,000 shares in secondary offering

Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.

Read more News

› Verified 2 days ago


Radiology Doctors in Albuquerque, NM

Mark Ehrhart, MD
Radiology
Medicare: Medicare Enrolled
Practice Location: Msc 10 5550, 1 University Of New Mexico, Albuquerque, NM 87131
Phone: 505-272-4661    
Dr. Shaya Ansari, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 8020 Constitution Pl Ne Ste 202, Albuquerque, NM 87110
Phone: 505-998-3096    Fax: 505-998-3100
Dr. Karen Renee Craig, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106
Phone: 505-272-0011    
Erika Jane Starks, MD, PHD
Radiology
Medicare: Medicare Enrolled
Practice Location: Radiology Msc 10-5530 1 University Of New Mexico, Albuquerque, NM 87131
Phone: 505-272-6225    
Stuart Bernard Paster,
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 8020 Constitution Place Ne, #101, Albuquerque, NM 87110
Phone: 505-998-1317    Fax: 505-998-1308
Danielle Eckart Sorte, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: Dept Of Radiology Msc 10 5530, 1 University Of New Mexico, Albuquerque, NM 87131
Phone: 801-641-5515    
Dr. Luis Centenera, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 4411 The 25 Way Ne, Suite 150, Albuquerque, NM 87109
Phone: 505-332-5800    Fax: 505-332-6919

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.